Literature DB >> 1568745

Pathologic observations of intrahepatic peribiliary glands in 1,000 consecutive autopsy livers: IV. Hyperplasia of intramural and extramural glands.

T Terada1, Y Nakanuma.   

Abstract

Hyperplastic changes of intrahepatic peribiliary glands have rarely been reported, with the exception of hepatolithiasis. To determine whether there are any hyperplastic changes in the glands in livers without hepatolithiasis, we examined 1,000 consecutive autopsy liver specimens that had no hepatolithiasis. The glands were divided into intramural mucous glands and extramural seromucous glands. The hyperplastic changes were found in "normal" livers and in livers with various hepatobiliary diseases, and they were classified into three categories: hyperplasia of intramural glands (49 cases; 4.9%), hyperplasia of extramural serous acini (35 cases; 3.5%), and hyperplasia of extramural mucous acini (92 cases; 9.2%). Two or more of these three hyperplastic changes occasionally coexisted in the same liver. Hyperplasia of intramural glands was seen rather evenly in normal livers and in livers with various hepatobiliary diseases. Prevalence of hyperplasia of extramural serous acini was high in intrahepatic cholangitis and submassive hepatic necrosis. Prevalence of hyperplasia of extramural mucous acini was high in cirrhosis, submassive hepatic necrosis, cholangitis, systemic infection, and extrahepatic biliary obstruction. The hyperplastic intramural glands and mucous acini of extramural glands contained more neutral, carboxylated, and sulfated mucin than normal glands. Although their pathogenesis is unclear, these hyperplastic changes may enhance seromucous secretion into biliary lumens and may lead to biliary dysfunctions such as retardation of bile flow and increased bile viscosity. These hyperplastic changes may be preexisting conditions predisposing to hepatolithiasis.

Entities:  

Mesh:

Year:  1992        PMID: 1568745     DOI: 10.1016/0046-8177(92)90124-l

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

Review 1.  The biliary tree--a reservoir of multipotent stem cells.

Authors:  Vincenzo Cardinale; Yunfang Wang; Guido Carpino; Gemma Mendel; Gianfranco Alpini; Eugenio Gaudio; Lola M Reid; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-28       Impact factor: 46.802

2.  Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity.

Authors:  Vincenzo Cardinale; Guido Carpino; Lola Reid; Eugenio Gaudio; Domenico Alvaro
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

3.  Cystic and micropapillary epithelial changes of peribiliary glands might represent a precursor lesion of biliary epithelial neoplasms.

Authors:  Yasunori Sato; Kenichi Harada; Motoko Sasaki; Yasuni Nakanuma
Journal:  Virchows Arch       Date:  2014-01-24       Impact factor: 4.064

4.  Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucins during intrahepatic bile duct development and maturation. An immunohistochemical study.

Authors:  M Sasaki; Y Nakanuma; T Terada; Y S Kim
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

5.  A Retrospective Case Control Study of Ductal Plate Malformation-like Features in Consecutive 200 Autopsies.

Authors:  Tadashi Terada
Journal:  Pathol Oncol Res       Date:  2017-02-24       Impact factor: 3.201

6.  Expression of transforming growth factor-alpha and its receptor during human liver development and maturation.

Authors:  T Terada; T Ohta; Y Nakanuma
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.

Authors:  Vincenzo Cardinale; Rossella Semeraro; Alessia Torrice; Manuela Gatto; Cristina Napoli; Maria Consiglia Bragazzi; Raffaele Gentile; Domenico Alvaro
Journal:  World J Gastrointest Oncol       Date:  2010-11-15

Review 8.  Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis.

Authors:  Fu Yu Li; Nan Sheng Cheng; Hui Mao; Li Sheng Jiang; Jing Qiu Cheng; Quan Sheng Li; Sanjay Munireddy
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

9.  Treatment of chronic proliferative cholangitis with c-myc shRNA.

Authors:  Fu-Yu Li; Nan-Sheng Cheng; Jing-Qiu Cheng; Hui Mao; Li-Sheng Jiang; Ning Li; Sheng He
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

10.  Cutaneous pseudolymphoma: a case report with an immunohistochemical study.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.